You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海南海藥(000566.SZ):擬將合計8.5億元財務資助額度期限延期一年
格隆匯 03-22 21:53

格隆匯3月22日丨海南海藥(000566.SZ)公佈,此前披露,公司根據公司資金需求和未來發展戰略需要,於2021年4月14日召開的第十屆董事會第十二次會議審議通過了《關於向新興際華醫藥控股有限公司借款的議案》。公司控股股東海南華同實業有限公司之控股股東新興際華醫藥控股有限公司(“醫藥控股”)向公司提供財務資助額度人民幣5億元,期限自2021年04月07日起至2022年04月06日止;公司於2021年6月1日召開的第十屆董事會第十六次會議審議通過了《關於向新興際華醫藥控股有限公司借款的議案》,醫藥控股向公司提供的財務資助額度人民幣3.5億元,期限自2021年5月31日起至2022年5月30日止。

為降低公司整體融資成本,保證公司業務運營的資金需求,公司於2022年3月21日召開第十屆董事會第二十二次會議,審議通過了《關於接受關聯方財務資助延期的議案》。公司擬將上述5億元及3.5億元的財務資助額度期限延期一年,在上述借款額度內,資金可以滾動使用,公司無需對該項財務資助提供任何抵押或擔保。此次借款延期的資金主要用於海南海藥主營業務及補充流動資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account